NextCure Net Income Applicable To Common Shares from 2010 to 2026
| NXTC Stock | USD 13.10 0.14 1.06% |
Net Loss | First Reported 2018-03-31 | Previous Quarter -16.1 M | Current Value -17.9 M | Quarterly Volatility 7.2 M |
Check NextCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NextCure's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 3.2 M or Interest Expense of 6.4 M, as well as many indicators such as Price To Sales Ratio of 14.65, Dividend Yield of 0.0 or PTB Ratio of 0.31. NextCure financial statements analysis is a perfect complement when working with NextCure Valuation or Volatility modules.
NextCure | Net Income Applicable To Common Shares | Build AI portfolio with NextCure Stock |
Analyzing NextCure's Net Income Applicable To Common Shares over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Applicable To Common Shares has evolved provides context for assessing NextCure's current valuation and future prospects.
Latest NextCure's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of NextCure over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. NextCure's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NextCure's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
NextCure Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (38,138,905) | |
| Coefficient Of Variation | (69.57) | |
| Mean Deviation | 23,839,642 | |
| Median | (22,799,000) | |
| Standard Deviation | 26,534,899 | |
| Sample Variance | 704.1T | |
| Range | 59.3M | |
| R-Value | (0.89) | |
| Mean Square Error | 151.8T | |
| R-Squared | 0.80 | |
| Slope | (4,693,677) | |
| Total Sum of Squares | 11265.6T |
NextCure Net Income Applicable To Common Shares History
About NextCure Financial Statements
NextCure stakeholders use historical fundamental indicators, such as NextCure's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although NextCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in NextCure's assets and liabilities are reflected in the revenues and expenses on NextCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in NextCure. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -67.3 M | -70.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NextCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NextCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nextcure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nextcure Stock:Check out the analysis of NextCure Correlation against competitors. For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Biotechnology sector continue expanding? Could NextCure diversify its offerings? Factors like these will boost the valuation of NextCure. Anticipated expansion of NextCure directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NextCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between NextCure's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NextCure should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, NextCure's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.